Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials

@article{Zhang2016PiracetamFA,
  title={Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials},
  author={Jie Zhang and Ruili Wei and Zhongqin Chen and Benyan Luo},
  journal={CNS Drugs},
  year={2016},
  volume={30},
  pages={575-587}
}
BackgroundAphasia is a common symptom in post-stroke patients. Piracetam is a commonly used nootropic agent that promises various benefits to brain function, including language improvement.ObjectiveWe performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients.MethodsRandomized controlled trials (RCTs) of piracetam treatment in post-stroke patients published in any language were included, excluding… Expand
Ten key reasons for continuing research on pharmacotherapy for post-stroke aphasia
ABSTRACT Background: Aphasia is a devastating disorder occurring in more than 30% of stroke victims. Speech and language therapy (SLT) is the treatment of choice for post-stroke aphasia (PSA) inExpand
The management of subacute and chronic vascular aphasia: an updated review
TLDR
The existing literature regarding available PSA management options, advances, and drawbacks pertaining to subacute and chronic phases are upgraded, yet the optimal dosage of the emerging high-intensity therapies is controversial. Expand
Efficacy of the Oriental herbal medicine, Jie Yu Dan, for alleviating post-stroke aphasia: A Systematic Review and meta-analysis of randomized clinical trials
TLDR
JYD might improve the efficacy of conventional therapy and/or acupuncture for treating post-stroke aphasia considering the quality of RCTs included, however, larger and highly controlled R CTs are needed to confirm the results. Expand
Functional recovery differences after stroke rehabilitation in patients with uni- or bilateral hemiparesis
TLDR
It is demonstrated that differences in functional recovery after stroke rehabilitation may be influenced by the site of hemiparesis after stroke. Expand
A physician survey of poststroke aphasia diagnosis and treatment in China
TLDR
The knowledge gaps exist among physicians in China regarding the assessment and management of PSA, and the improved awareness of the available guidelines/consensus could improve the performance of the physicians. Expand
Pharmacological Treatment of Post-stroke Cognitive Deficits
TLDR
The state-of-the-art of pharmacotherapy for PSCD is reviewed together with the theoretical rationale for using drugs in three highly prevalent stroke-related conditions, aphasia, neglect and VCI. Expand
Effects of butylphthalide combined with Naofukang on cognitive function and the expression of serum neurotrophic factor in patients with vascular dementia
Objective: This study aimd to determine the effect of butylphthalide combined with Naofukang on cognitive function and serum neurotrophic factor level in patients with vascular dementia. Methods: AExpand
Rehabilitation of Communication Disorders
TLDR
The predominant communication disorders post-stroke include aphasia, dysarthria and apraxia of speech, and 18 evidence-based recommendations for the assessment and treatment of communication disorders acquired after stroke are outlined. Expand
Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function
TLDR
Piracetam at therapeutically relevant concentrations improves neuritogenesis in the human cell line SH-SY5Y over conditions mirroring the whole spectrum of age-associated cognitive decline and suggests the mPTP as an important target for the beneficial effects of piracetam on mitochondrial function. Expand
Neues zur Neurorehabilitation: Motorik und Sprache
TLDR
Evidence-based neurorehabilitative interventions to promote motor and language recovery in the acute and chronic post-stroke stages are presented and an outlook on promising future interventions for stroke neurore Rehabilitation is provided. Expand
...
1
2
...

References

SHOWING 1-10 OF 53 REFERENCES
Effect of Low-Frequency rTMS on Aphasia in Stroke Patients: A Meta-Analysis of Randomized Controlled Trials
TLDR
Low-frequency rTMS with a 90% resting motor threshold that targets the triangular part of the right inferior frontal gyrus (IFG) has a positive effect on language recovery in patients with aphasia following stroke. Expand
Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
TLDR
Piracetam taken orally in a daily dose of 4.8 g for 6 months has no clear beneficial effect on post-stroke language disorders. Expand
Piracetam Treatment in Post-Stroke Aphasia
TLDR
Two double-blind placebo-controlled studies in patients with chronic aphasia have demonstrated a beneficial effect of oral piracetam 4.8 g/day preceded by intravenous bolus injection of 12g, as measured by improvement in some functionally important scores of the Aachen Aphasia Test. Expand
Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
TLDR
Piracetam appears to have a positive adjuvant effect on the recovery of aphasia in patients receiving intensive language therapy in a double-blind, placebo-controlled parallel group study. Expand
The role of piracetam in the treatment of acute and chronic aphasia.
  • W. Huber
  • Psychology, Medicine
  • Pharmacopsychiatry
  • 1999
TLDR
Two randomized double-blind placebo-controlled studies performed which utilised the Aachen Aphasia Test (AAT), a validated and standardized procedure, indicate that piracetam improves aphasia in acute stroke and, as an adjuvant to language therapy, in post-acute and chronic aphasIA. Expand
Effect of Piracetam on Recovery and Rehabilitation After Stroke: A Double‐Blind, Placebo‐Controlled Study
TLDR
An improvement in aphasia in patients undergoing rehabilitation after a stroke after 12 weeks' treatment with piracetam is shown, but an effect on tests of activities of daily living is unable to be demonstrated and the effect on perceptual deficit is not confirmed. Expand
Piracetam Improves Activated Blood Flow and Facilitates Rehabilitation of Poststroke Aphasic Patients
TLDR
Piracetam as an adjuvant to speech therapy improves recovery of various language functions, and this effect is accompanied by a significant increase of task-related flow activation in eloquent areas of the left hemisphere. Expand
A Systematic Review and Meta-Analysis of the Efficacy of Piracetam and Piracetam-Like Compounds in Experimental Stroke
TLDR
The evidence supporting a protective effect of piracetam and its derivatives in animal models of stroke is described, but concerns are raised about the amount of available data, the quality of the studies and publication bias. Expand
Pharmacological treatment for aphasia following stroke.
TLDR
Drug treatment with piracetam may be effective in the treatment of aphasia after stroke, and researchers should examine the long term effects of this treatment, and whether it is more effective than speech and language therapy. Expand
Poststroke Aphasia
TLDR
Data from single-case studies, case series and an open-label study suggest that donepezil may have beneficial effects on chronic poststroke aphasia, and preliminary evidence suggests that didpezil is well tolerated and its efficacy is maintained in the long term. Expand
...
1
2
3
4
5
...